Dr Daniela Marino is the Co-Founder and CEO of CUTISS. During her PhD in Sciences from ETHZ, she focused her research on vascular biology and stem cells. She then joined a research group at UZH as post doc and before starting CUTISS, she was the co-leader and business developer for the project denovoSkin™ at the Wyss Zurich. She co-founded CUTISS, where denovoSkin™ is being developed towards commercialization. denovoSkin™ is a personalized human skin graft that can be bio-engineered in large quantities. It promises to grow with the patient, limit scarring, and drastically reduce the number of follow up corrective surgeries required, particularly in children.
